Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Findings raise concern over bTB tests
Scientists have confirmed a case of Mycobacterium Microti infection in a cow in France.

Mycobacterium Microti infection confirmed in a cow in France

Scientists have confirmed a case of Mycobacterium Microti infection in a cow in France, raising concern over the reliability of diagnostic tests used for bovine TB (bTB) surveillance.

Reporting in Veterinary Record (Vol 180 No 17), researchers say the discovery follows an investigation of M Microti infection in a dairy goat in the same region.

Communicating the finding in 2015, the team demonstrated that the bacteria could be responsible for misleading diagnostic results for bTB.

In this latest study, researchers found that the suspected cattle herd had shared the same pasture with two bTB confirmed herds. As such, they submitted the herd for testing and culled one animal ‘with a doubtful result’ for direct diagnosis.

An analysis revealed the cow harboured the same genotype of M microti that was identified in the goat, as well as a badger that was living in the same area.

M Microti is a member of the Mycobacterium tuberculosis complex (MTBC), which also includes major human and animal pathogens like M tuberculosis and Mycobacterium bovis. It was first described as the cause of tuberculosis in small wild mammals, but it can also infect other species - including humans.

Previously in the UK, M microti has been isolated in skin test reactor cattle, demonstrating the risk of infection in livestock and of interference with bTB diagnosis.
The researchers believe that all these findings raise concerns about the reliability of diagnostic tests used for bTb surveillance.

‘The use of highly specific tests based on specific antigens such as ESAT6 and CFP10 (which are absent in M microti and already currently used in the interferon gamma test employed in France) are highly recommended to accurately identify M Bovis infection at antemortem examination,’ they write.

'At postmortem diagnosis, the use of specific molecular tools should be considered to rapidly distinguish pathogens within the MTBC and to avoid misleading diagnosis’.

The research was led by scientists from ANSES - the French agency for Food, Environmental and Occupational Health & Safety. 

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com